日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML

对于FLT3-ITD突变型急性髓系白血病患者,可测量的残留病灶和移植后吉瑞替尼维持治疗。

Levis, Mark J; Hamadani, Mehdi; Logan, Brent R; Jones, Richard J; Singh, Anurag K; Litzow, Mark R; Wingard, John R; Papadopoulos, Esperanza B; Perl, Alexander E; Soiffer, Robert J; Ustun, Celalettin; Oshima, Masumi Ueda; Uy, Geoffrey L; Waller, Edmund K; Vasu, Sumithira; Solh, Melhem; Mishra, Asmita; Muffly, Lori S; Kim, Hee-Je; Stelljes, Matthias; Najima, Yuho; Onozawa, Masahiro; Thomson, Kirsty; Nagler, Arnon; Wei, Andrew H; Marcucci, Guido; Chen, Caroline; Hasabou, Nahla; Rosales, Matt; Hill, Jason; Gill, Stanley C; Nuthethi, Rishita; King, Denise; Mendizabal, Adam; Devine, Steven M; Horowitz, Mary M; Chen, Yi-Bin

Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702

尿液无反应标准预测多发性骨髓瘤的无进展生存期:BMT CTN 0702 的事后分析

Banerjee, Rahul; Fritz, Amber R; Akhtar, Othman S; Freeman, Ciara L; Cowan, Andrew J; Shah, Nina; Landau, Heather J; Kumar, Shaji K; Vogl, Dan T; Efebera, Yvonne A; McCarthy, Philip L; Vesole, David H; Mendizabal, Adam; Krishnan, Amrita Y; Somlo, George; Stadtmauer, Edward A; Pasquini, Marcelo C

Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia

移植预处理、NPM1突变和可测量残留病灶对FLT3-ITD急性髓系白血病的影响

Levis, Mark J; Hamadani, Mehdi; Logan, Brent R; Jones, Richard J; Singh, Anurag K; Litzow, Mark R; Wingard, John R; Papadopoulos, Esperanza B; Perl, Alexander E; Soiffer, Robert J; Ustun, Celalettin; Oshima, Masumi Ueda; Uy, Geoffrey L; Waller, Edmund K; Vasu, Sumithira; Solh, Melhem; Mishra, Asmita; Muffly, Lori S; Kim, Hee-Je; Stelljes, Matthias; Najima, Yuho; Onozawa, Masahiro; Thomson, Kirsty; Chen, Caroline; Hasabou, Nahla; Rosales, Matt; Hill, Jason E; Gill, Stanley C; Nuthethi, Rishita; King, Denise; Mendizabal, Adam; Devine, Steven M; Horowitz, Mary M; Chen, Yi-Bin

Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease

造血干细胞移植与镰状细胞病青少年和青年患者的标准治疗比较

Walters, Mark C; Eapen, Mary; Liu, Yiwen; El Rassi, Fuad; Waller, Edmund K; Levine, John E; Strouse, John J; Antin, Joseph H; Parikh, Suhag H; Bakshi, Nitya; Dampier, Carlton; Jaroscak, Jennifer J; Bergmann, Shayla; Wong, Trisha; Kota, Vamsi; Pace, Betty; Lekakis, Lazaros J; Lulla, Premal; Nickel, Robert S; Kasow, Kimberly A; Popat, Uday; Smith, Wally; Yu, Lolie; DiFronzo, Nancy; Geller, Nancy; Kamani, Naynesh; Klings, Elizabeth S; Hassell, Kathryn; Mendizabal, Adam; Sullivan, Keith; Neuberg, Donna; Krishnamurti, Lakshmanan

Representativeness of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Trial Participants

血液和骨髓移植临床试验网络(BMT CTN)试验参与者的代表性

Kaur, Manmeet; Horowitz, Mary M; Mendizabal, Adam; Chen, Min; Foley, Amy; Auletta, Jeffery J; Devine, Steven; D'Souza, Anita

Haploidentical Bone Marrow Transplantation for Sickle Cell Disease

镰状细胞病的单倍体相合骨髓移植

Kassim, Adetola A; Walters, Mark C; Eapen, Mary; Smith, Madoc; Logan, Brent R; Solh, Melhem; McKinney, Christopher; Nieder, Michael; Ross, Maureen; Kent, Michael; Abusin, Ghada A; Mallhi, Kanwaldeep; Silva, Jorge Galvez; Shaughnessy, Paul; Kanter, Julie; Haines, Hilary; Farah, Rafic; Khaled, Yasser A; Ritzau, Nicole; Mendizabal, Adam; Abraham, Allistair; Bollard, Catherine; Cooke, Kenneth; de la Fuente, Josu; Hanna, Rabi; Horowitz, Mary M; Jordan, Lori C; Bakshi, Nitya; Krishnamurti, Lakshmanan; Leifer, Eric; Mahadeo, Kris Michael; Shenoy, Shalini; Jones, Richard J; DeBaun, Michael R; Brodsky, Robert A

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3

吉瑞替尼用于FLT3内部串联重复突变型急性髓系白血病移植后维持治疗

Levis, Mark J; Hamadani, Mehdi; Logan, Brent; Jones, Richard J; Singh, Anurag K; Litzow, Mark; Wingard, John R; Papadopoulos, Esperanza B; Perl, Alexander E; Soiffer, Robert J; Ustun, Celalettin; Ueda Oshima, Masumi; Uy, Geoffrey L; Waller, Edmund K; Vasu, Sumithra; Solh, Melhem; Mishra, Asmita; Muffly, Lori; Kim, Hee-Je; Mikesch, Jan-Henrik; Najima, Yuho; Onozawa, Masahiro; Thomson, Kirsty; Nagler, Arnon; Wei, Andrew H; Marcucci, Guido; Geller, Nancy L; Hasabou, Nahla; Delgado, David; Rosales, Matt; Hill, Jason; Gill, Stanley C; Nuthethi, Rishita; King, Denise; Wittsack, Heather; Mendizabal, Adam; Devine, Steven M; Horowitz, Mary M; Chen, Yi-Bin

Correction: Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401

更正:树突状细胞/骨髓瘤融合疫苗联合来那度胺维持治疗多发性骨髓瘤一线自体造血干细胞移植后的随机II期试验:BMT CTN 1401

Chung, David J; Shah, Nina; Wu, Juan; Logan, Brent; Bisharat, Lina; Callander, Natalie; Cheloni, Giulia; Anderson, Kenneth; Chodon, Thinle; Dhakal, Binod; Devine, Steve; Dutt, Poorvi Somaiya; Efebera, Yvonne; Geller, Nancy; Ghiasuddin, Haider; Hematti, Peiman; Holmberg, Leona; Howard, Alan; Johnson, Bryon; Karagkouni, Dimitra; Lazarus, Hillard M; Malek, Ehsan; McCarthy, Philip; McKenna, David; Mendizabal, Adam; Nooka, Ajay; Munshi, Nikhil; O'Donnell, Lynn; Patel, Krina; Rapoport, Aaron P; Reese, Jane; Rosenblatt, Jacalyn; Soiffer, Robert; Stroopinsky, Dina; Uhl, Lynne; Vlachos, Ioannis S; Waller, Edmund K; Young, James W; Pasquini, Marcelo C; Avigan, David

Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401.

树突状细胞/骨髓瘤融合疫苗联合来那度胺维持治疗多发性骨髓瘤一线自体造血细胞移植的随机 II 期试验:BMT CTN 1401

Chung David J, Shah Nina, Wu Juan, Logan Brent, Bisharat Lina, Callander Natalie, Cheloni Giulia, Anderson Kenneth, Chodon Thinle, Dhakal Binod, Devine Steve, Somaiya Dutt Poorvi, Efebera Yvonne, Geller Nancy, Ghiasuddin Haider, Hematti Peiman, Holmberg Leona, Howard Alan, Johnson Bryon, Karagkouni Dimitra, Lazarus Hillard M, Malek Ehsan, McCarthy Philip, McKenna David, Mendizabal Adam, Nooka Ajay, Munshi Nikhil, O'Donnell Lynn, Rapoport Aaron P, Reese Jane, Rosenblatt Jacalyn, Soiffer Robert, Stroopinsky Dina, Uhl Lynne, Vlachos Ioannis S, Waller Edmund K, Young James W, Pasquini Marcelo C, Avigan David

Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome

一项针对50-75岁晚期骨髓增生异常综合征患者的基于供体可用性的减低强度造血干细胞移植的生物学分配试验

Nakamura, Ryotaro; Saber, Wael; Martens, Michael J; Ramirez, Alyssa; Scott, Bart; Oran, Betul; Leifer, Eric; Tamari, Roni; Mishra, Asmita; Maziarz, Richard T; McGuirk, Joseph; Westervelt, Peter; Vasu, Sumithira; Patnaik, Mrinal; Kamble, Rammurti; Forman, Stephen J; Sekeres, Mikkael A; Appelbaum, Frederick; Mendizabal, Adam; Logan, Brent; Horowitz, Mary; Cutler, Corey